Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion

Dario R. Roque; Daniela Matei

doi:10.1200/JCO.21.02667

Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion

Dario R. Roque, Daniela Matei^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	924-926
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	40
Issue number	9
DOIs	https://doi.org/10.1200/JCO.21.02667
State	Published - Mar 20 2022

Funding

Supported by NCI P20 CA233304 (D.M. and D.R.R.) and the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (D.R.R.).

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.21.02667

Cite this

@article{3b712cd13b4645a7a47bcc408b905957,

title = "Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion",

author = "Roque, {Dario R.} and Daniela Matei",

note = "Funding Information: Supported by NCI P20 CA233304 (D.M. and D.R.R.) and the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (D.R.R.).",

year = "2022",

month = mar,

day = "20",

doi = "10.1200/JCO.21.02667",

language = "English (US)",

volume = "40",

pages = "924--926",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "9",

}

TY - JOUR

T1 - Paclitaxel and Carboplatin for Uterine Carcinosarcoma

T2 - A Path to Inclusion

AU - Roque, Dario R.

AU - Matei, Daniela

N1 - Funding Information: Supported by NCI P20 CA233304 (D.M. and D.R.R.) and the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (D.R.R.).

PY - 2022/3/20

Y1 - 2022/3/20

UR - http://www.scopus.com/inward/record.url?scp=85126682632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126682632&partnerID=8YFLogxK

U2 - 10.1200/JCO.21.02667

DO - 10.1200/JCO.21.02667

M3 - Review article

C2 - 35044808

AN - SCOPUS:85126682632

SN - 0732-183X

VL - 40

SP - 924

EP - 926

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 9

ER -

Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this